Health Catalyst, Inc. (HCAT) Cut to Equal Weight at Wells Fargo on Prolonged Revenue, Margin Pressure

Health Catalyst, Inc. (NASDAQ:HCAT) is one of the best Robinhood stocks on this list.

Health Catalyst, Inc. (HCAT) Cut to Equal Weight at Wells Fargo on Prolonged Revenue, Margin Pressure

TheFly reported on March 18 that Wells Fargo lowered its rating on HCAT to Equal Weight from Overweight and slashed its price target from $5 to $1. According to the firm, recent sales and strategic adjustments are unlikely to boost performance in the near future, and revenue and margin issues are anticipated to persist through 2027. Noting that the corporation does not seem to have a clear short-term solution, Wells Fargo likewise lowered its projections.

Additionally, as part of its March 12 earnings announcement, Health Catalyst, Inc. (NASDAQ:HCAT) released its fiscal first quarter 2026 guidance along with results for the quarter and year that concluded on December 31, 2025. Alongside the announcement, management emphasized that, under CEO Ben Albert’s direction, it is concentrating on improving long-term execution and fixing operational flaws.

HCAT estimated that overall revenue for the first quarter of 2026 would be between $68 million and $70 million. Additionally, the business projected Adjusted EBITDA to be between $7 and $8 million. The release’s financial outlook portion contained the guidance, which represented management’s expectations for short-term business performance as it strives to enhance execution and set up the company for long-term success.

Health Catalyst, Inc. (NASDAQ:HCAT) is a healthcare data and analytics company that provides cloud-based software and professional services to help hospitals and health systems improve clinical, financial, and operational performance.

While we acknowledge the risk and potential of HCAT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HCAT and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years. 

Disclosure: None. Follow Insider Monkey on Google News.